Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent — T3PROJECT  

Peripheral Artery Disease (PAD) Clinical Trial

Official title: Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent

Status Not yet recruiting

Clinical Trial Summary

The purpose of this post-authorization registry is to describe the clinical outcomes of de novo and restenotic lesions in the superficial femoral and/or popliteal artery treated with the PULSAR® -18 T3 stent, implanted both primary and salvage.

Clinical Trial Description

Post-authorization, prospective and multicenter registry to evaluate the clinical results of the PULSAR® -18 T3 stent, in the treatment of de novo or restenotic lesions of the superficial femoral and/or popliteal artery, primarily as salvage, in a population of patients residing in Spain and in "real life" conditions. In this registry, data will be collected from approximately 100 consecutive patients who have been treated with the PULSAR® -18 T3 Stent. Subjects with PAD treated with the PULSAR® -18 T3 Stent will be assessed for eligibility for the registry and will be consecutively included in the registry. Once informed consent is obtained, the required data will be collected. ;

Related Conditions & MeSH terms

• Peripheral Arterial Disease
• Peripheral Artery Disease (PAD)

• NCT number: NCT05665816
• Study type: Observational [Patient Registry]
• Source: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
• Contact: Jorge Cuenca Manteca, MD
• Phone: 968128600
• Email: jcuencam@gmail.com
• Status: Not yet recruiting
• Start date: January 15, 2023
• Completion date: May 15, 2024